Clinical Trial Update: INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial named INHALE-1st is evaluating Afrezza (insulin human inhalation powder) for youth newly diagnosed with Type 1 diabetes mellitus and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: RECRUITING